Bank of New York Mellon’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-127,474
| Closed | -$17.9M | – | 4300 |
|
|
2018
Q4 | $17.9M | Sell |
127,474
-5,674
| -4% | -$861K | 0.01% | 1548 |
|
|
2018
Q3 | $22.7M | Sell |
133,148
-2,414
| -2% | -$406K | 0.01% | 1548 |
|
|
2018
Q2 | $23.5M | Buy |
135,562
+13,033
| +11% | +$1.96M | 0.01% | 1504 |
|
|
2018
Q1 | $14.1M | Buy |
122,529
+17,298
| +16% | +$1.84M | ﹤0.01% | 1798 |
|
|
2017
Q4 | $8.86M | Sell |
105,231
-16,327
| -13% | -$1.36M | ﹤0.01% | 2052 |
|
|
2017
Q3 | $11.2M | Buy |
121,558
+4,018
| +3% | +$312K | ﹤0.01% | 1934 |
|
|
2017
Q2 | $9.43M | Buy |
117,540
+15,098
| +15% | +$837K | ﹤0.01% | 2003 |
|
|
2017
Q1 | $4.31M | Buy |
102,442
+30,210
| +42% | +$1.24M | ﹤0.01% | 2404 |
|
|
2016
Q4 | $2.32M | Buy |
72,232
+6,465
| +10% | +$166K | ﹤0.01% | 2763 |
|
|
2016
Q3 | $1.72M | Sell |
65,767
-31,370
| -32% | -$821K | ﹤0.01% | 2849 |
|
|
2016
Q2 | $2.25M | Buy |
97,137
+26,600
| +38% | +$662K | ﹤0.01% | 2644 |
|
|
2016
Q1 | $1.93M | Buy |
70,537
+30,646
| +77% | +$641K | ﹤0.01% | 2680 |
|
|
2015
Q4 | $1.14M | Buy |
39,891
+5,974
| +18% | +$160K | ﹤0.01% | 3087 |
|
|
2015
Q3 | $593K | Sell |
33,917
-9,618
| -22% | -$188K | ﹤0.01% | 3507 |
|
|
2015
Q2 | $786K | Buy |
43,535
+9,970
| +30% | +$136K | ﹤0.01% | 3467 |
|
|
2015
Q1 | $417K | Buy |
33,565
+13,301
| +66% | +$166K | ﹤0.01% | 3680 |
|
|
2014
Q4 | $238K | Buy |
20,264
+1,091
| +6% | +$12.7K | ﹤0.01% | 3848 |
|
|
2014
Q3 | $252K | Buy |
+19,173
| New | +$249K | ﹤0.01% | 3832 |
|
Other funds holding LOXO
Bank of New York Mellon's LOXO Position: Q1 2019 in Review
Bank of New York Mellon sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 127,474 shares — an estimated $17.9M sold.
Bank of New York Mellon first reported a position in LOXO in Q3 2014 and held it in 18 quarters. The position peaked at $23.5M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Bank of New York Mellon reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Bank of New York Mellon sold 127,474 Loxo Oncology, Inc shares in Q1 2019, an estimated $17.9M.
- Bank of New York Mellon first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 18 quarters.
- Bank of New York Mellon's Loxo Oncology, Inc position peaked at $23.5M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Bank of New York Mellon's 13F filing for Q1 2019, filed 14 May 2019.